세계의 CRO(임상시험수탁기관) 서비스 시장 규모는 2024년 1,118억 달러에서 예측 기간 중 8.2%의 CAGR로 추이하며, 2029년말에는 1,660억 달러에 달할 것으로 예측됩니다.
임상시험 부문은 2024년 841억 달러에서 예측 기간 중 8.5%의 CAGR로 추이하며, 2029년말에는 1,265억 달러에 달할 것으로 예측됩니다. 전임상 연구 부문은 2024년 139억 달러에서 CAGR 8.0%로 추이하며, 2029년말에는 205억 달러에 달할 것으로 예측됩니다.
세계의 CRO(임상시험수탁기관) 서비스 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 신규 기술 및 기술개발의 동향, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 개요
제2장 시장 개요
- 개요
- Porter's Five Forces 분석
제3장 시장 역학
- 시장 역학
- 시장 성장 촉진요인
- CRO에서 AI의 도입 증가
- 바이오테크놀러지 및 제약 기업에 대한 연구개발 투자
- 만성질환 및 면역 질환의 세계 만연
- CRO가 효율성을 높인다.
- 시장 성장 억제요인
- CRO 아웃소싱의 과제
- 숙련 전문가의 부족
- 시장 기회
- 무기적 전략
제4장 규제 상황
- FDA의 규제와 영향
- 스폰서 활동에 관한 규제
- CDISC 표준
- BIMO 프로그램
- 유럽 규격
제5장 신규 기술
- 개요
- 컴퓨터 기반 기술
- 분산형 임상시험
- 첨단 분석과 시뮬레이션
제6장 시장 세분화 분석
- 세분화 내역
- 세계의 CRO 서비스 시장 : 기능별
- 세계 시장 규모·예측
- 임상시험
- 전임상 연구
- Drug Discovery
- 중앙 실험실
- 세계의 CRO 서비스 시장 : 치료 영역별
- 세계 시장 규모·예측
- 종양
- 심장병
- 대사
- 신경
- 면역
- 기타
- 세계의 CRO 서비스 시장 : 최종사용자별
- 세계 시장 규모·예측
- 바이오의약품 기업
- 학술연구기관
- 지역적 내역
- 세계의 CRO 서비스 시장 : 지역별
- 세계 시장 규모·예측
- 북미
- 유럽
- 아시아태평양
- 기타
제7장 경쟁 정보
제8장 CRO 서비스 시장의 지속가능성 : ESG 관점
- ESG : 서론
- CRO 서비스 시장의 지속가능성
- ESG의 시점
- 환경에 대한 영향
- 사회적 영향
- 거버넌스
제9장 부록
- 조사 방법
- 약어
- 전시
- 기업 개요
- CHARLES RIVER LABORATORIES
- FRONTAGE LABS.
- ICON PLC
- IQVIA INC.
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- MEDPACE
- PAREXEL INTERNATIONAL CORP.
- SYNEOS HEALTH
- THERMO FISHER SCIENTIFIC INC.
- WUXI APPTEC
KSA
The global market for contract research organization (CRO) services is expected to grow from $111.8 billion in 2024 and is projected to reach $166.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
The global market for clinical trials functional services of CRO is expected to grow from $84.1 billion in 2024 and is projected to reach $126.5 billion by the end of 2029, at a CAGR of 8.5% during the forecast period of 2024 to 2029.
The global market for preclinical research functional services of CRO is expected to grow from $13.9 billion in 2024 and is projected to reach $20.5 billion by the end of 2029, at a CAGR of 8.0% during the forecast period of 2024 to 2029.
Report Scope
This report analyzes the global contract research organization (CRO) services market and will cover all the major global CRO companies. It provides a comprehensive overview of the clinical trial process, including a detailed description of all the phases and functional services CROs associated with clinical trials; and it details the major therapeutic areas covered by CROs and their broad service offerings.
As part of this analysis, the CRO services market is divided by functional services into the following market segments: clinical trials services, preclinical research, drug discovery and central lab. It is segmented by therapeutic area into the following markets: oncology, cardiology, metabolic, neurology, immunology and other applications (such as CNS, respiratory and genetic diseases). Based on end user, it is segmented into biopharmaceutical companies as well as academic research institutions.
The global CRO services market is also segmented by geography into these regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). The regional analysis includes a detailed examination of the major countries operating in this market such as the U.S., Germany, the U.K., France, Japan, China and India.
This report analyzes the market trends associated with CRO services using data from 2023, which serves as the base year. Market estimates are provided for 2024, and forecasts of compound annual growth rates are given for the period 2024 through 2029. The report will also highlight the current and future potential of the CRO services market, and will give a detailed analysis of this market's competitive landscape by covering regulatory scenarios, drivers, restraints and opportunities, as well as the market share of key players.
Emerging trends and changing market dynamics within the CRO industry are also analyzed in detail in this report.
This report's goals include:
- Analyzing technologies and applications.
- Analyzing global market size and segmentation.
- Understanding market constraints and drivers.
- Providing detailed market forecasts through 2029.
- Assessing market shares, competitiveness and industry structure.
- Identifying potential long-term impacts on the CRO services market.
Report Includes
- 86 data tables and 33 additional tables
- An overview of the current and future global market for contract research organization (CRO) services
- Analyses of global market trends, with market revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
- Estimates of the market size and revenue forecasts for the global CRO market, with market share analysis based on functional services, therapeutic area, end user, and region
- Information on CDISC standards, and regulations on sponsor activities; discussion of the impact of FDA regulations on the pharmaceutical industry and the potential long-term impacts of CROs on the drug discovery technologies market
- Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
- Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices followed by leading companies, their ESG ratings, and consumer attitudes
- Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
- Profiles of the leading companies, including IQVIA Inc., PPD Inc., ICON plc., Charles River Laboratories International Inc., and LabCorp.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of the Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Porter's Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Adoption of AI in CROs
- R&D Investment in Biotech & Pharma Companies
- Rising Prevalence of Chronic and Immunological Diseases Globally
- CROs Add Efficiency
- Market Restraints
- Challenges in CRO Outsourcing
- Shortage of Skilled Professionals
- Market Opportunities
- Inorganic Strategies
Chapter 4 Regulatory Landscape
- FDA Regulation and Impact
- Regulations on Sponsor Activities
- CDISC Standards
- BIMO Program
- European Standards
Chapter 5 Emerging Technologies
- Overview
- Computer-Based Techniques
- Decentralized Clinical Trials
- Advanced Analytics and Simulation
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market CRO Services by Functional Services
- Global Market Size and Forecast
- Clinical Trials
- Preclinical Research
- Drug Discovery
- Central Lab
- Global Market for CRO Services by Therapeutic Area
- Global Market Size and Forecast
- Oncology
- Cardiology
- Metabolic
- Neurology
- Immunology
- Other Applications
- Global Market for CRO Services, by End User
- Global Market Size and Forecast
- Biopharmaceutical Companies
- Academic Research Institutions
- Geographic Breakdown
- Global Market for CRO Services by Region
- Global Market Size and Forecast
- North America
- Europe
- Asia-Pacific
- Rest of World
Chapter 7 Competitive Intelligence
- Overview
- Competitive Landscape
- Mergers and Acquisitions
- SWOT Analysis
- Strengths of the Global Market for CRO Services
- Weaknesses of the Global Market for CRO Services
- Opportunities in the Global Market for CRO Services
- Threats to the Global Market for CRO Services
Chapter 8 Sustainability in CRO Services Market: An ESG Perspective
- Introduction to ESG
- Sustainability in the CRO Services Market
- ESG Perspective
- Environmental Impact
- Social Impact
- Governance
Chapter 9 Appendix
- Methodology
- Abbreviations
- Sources
- Company Profiles
- CHARLES RIVER LABORATORIES
- FRONTAGE LABS.
- ICON PLC
- IQVIA INC.
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- MEDPACE
- PAREXEL INTERNATIONAL CORP.
- SYNEOS HEALTH
- THERMO FISHER SCIENTIFIC INC.
- WUXI APPTEC
